User menu

Invitro Antitumor Activities of a Novel 2/3 Condensation Product of Salicylaldoxime With Di-n-butyltin(iv) Oxide

Bibliographic reference Boualam, M. ; Biesemans, M. ; Meunierpiret, J. ; Willem, R. ; Gielen, M.. Invitro Antitumor Activities of a Novel 2/3 Condensation Product of Salicylaldoxime With Di-n-butyltin(iv) Oxide.INTERNATIONAL CONF ON ENVIRONMENTAL AND BIOLOGICAL ASPECTS OF MAIN-GROUP ORGANOMETALS ( ICEBAMO ) (PADUA(Italy), Sep 15-19, 1991). In: Applied Organometallic Chemistry, Vol. 6, no. 2, p. 197-205 (1992)
Permanent URL http://hdl.handle.net/2078.1/63591
  1. and In vitro antitumor activity of organotin compounds In: Metal-Based Antitumor Drugs, vol 2, (ed), Freund, Tel Aviv, in press
  2. and In vitro antitumour activity of organotin(IV) derivatives of salicylic acid and related compounds In: Metal Complexes in Cancer Chemotherapy, (ed), VCH, in press
  3. and (Pharmachemie BV) European Patent 90202316.7-, 21 September 1990
  4. and in preparation
  5. Van Lambalgen, Invest. New Drugs, 5, 161 (1987)
  6. Status of the NCI preclinical antitumor drug discovery screen. In: Principles and Practices of Oncology, vol 3, No 10, JB Lippincott, 1989
  7. and Anticancer Res., 1992, in press
  8. The antitumor activity of tin compounds. In: Metal-Based Antitumor Drugs, ( (ed), Freund, London), 1988, pp 103-149
  9. and Organometallics in Cancer Chemotherapy, vol 1, Main Group Metal Compounds, CRC Press, Boca Raton, 1989
  10. and Anticancer Res., 1992, in press